Sanofi may appeal French competition body fine
PARIS May 14 (Reuters) - French drugmaker Sanofi said on Tuesday it objected to a fine by the French Competition Authority in a dispute over generic competition to its blood thinner, Plavix, and said it was considering a possible appeal.
The Competition Authority said it fined Sanofi 40.6 million euros ($52.7 million) over what it called a smear campaign aimed at stifling generic competition to Plavix. ($1 = 0.7703 euros) (Reporting by Dominique Vidalon; Editing by James Regan)
- Tearful Thai PM urges protesters to take part in election
- Google bus blocked in San Francisco gentrification protest
- North Korea's "reign of terror" worries South's leader
- Chinese hackers spied on Europeans before G20 meeting: researcher
- Putin dissolves state news agency, tightens grip on Russia media